ONCY - Oncolytics Biotech GAAP EPS of -$0.14 misses by $0.07
- Oncolytics Biotech press release ( NASDAQ: ONCY ): Q4 GAAP EPS of -$0.14 misses by $0.07 .
- As of December 31, 2022, the Company reported $32.1 million in cash, cash equivalents and marketable securities.
For further details see:
Oncolytics Biotech GAAP EPS of -$0.14 misses by $0.07